CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cepheid is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cepheid
904 East Caribbean Drive
Phone: (408) 541-4191p:408 541-4191 Sunnyvale, CA  94089-1189  United States Ticker: XEPXEP
This company was Merged or Acquired on 11/4/2016.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201612/31/2015YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer John L.Bishop 71 2/12/2013 4/1/2002
President, Chief Operating Officer Warren C.Kocmond 56 2/9/2016 5/6/2013
Chief Financial Officer, Executive Vice President Daniel E.Madden 48 8/13/2015 6/1/2014
10 additional Officers and Directors records available in full report.

Business Names
Business Name
Cepheid (Shanghai) Diagnostics Co., Ltd.
Cepheid AB
Cepheid Benelux
14 additional Business Names available in full report.

General Information
Number of Employees: 1,700 (As of 12/31/2015)
Outstanding Shares: 73,480,343 (As of 10/27/2016)
Shareholders: 103
Stock Exchange: NASD
Federal Tax Id: 770441625
Fax Number: (408) 541-4192


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023